VP Strategy and Translation @ (May 2017 - Present)
CSO Moderna Therapeutics Sweden @ (September 2014 - March 2017)
Head, AstraZeneca Translational Science Centre, Karolinska Institutet @ (July 2012 - September 2014)
Laboratory Head @ AstraZeneca R&D (December 2010 - July 2012)
Principal Scientist @ (January 2010 - December 2010)
Hugh Salter Education
University of Cambridge
PhD
1986-1990
University of Leeds
BSc (Genetics)
1983-1986
Hugh Salter Skills
Target Identification
Drug Discovery
Translational Science
Human Genetics
Biomarker Discovery
Biomarker Development
Line Management
Bioinformatics
Neuroscience
Biomarkers
Translational Research
Translational Medicine
Drug Development
Clinical Development
Systems Biology
Genetics
Immunology
R&D
Genomics
Inflammation
Neurodegeneration
Molecular Biology
Biochemistry
Pharmacology
In Vivo
Research and Development (R&D)
Research And Development R&D
Research and Development
Hugh Salter Summary
Hugh Salter, based in Stockholm, SE, is currently a Chief Scientific Officer at Anocca AB. Hugh Salter brings experience from previous roles at Anocca AB, Moderna Therapeutics, AstraZeneca and AstraZeneca R&D. Hugh Salter holds a 1986 - 1990 PhD @ University of Cambridge. With a robust skill set that includes Target Identification, Drug Discovery, Translational Science, Human Genetics, Biomarker Discovery and more. Hugh Salter has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Hugh Salter?
Find contact details for 700 million professionals.